{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:15:17Z","timestamp":1790727317930,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bbi.2025.01.029","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:03:57Z","timestamp":1738757037000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Decreased neutrophil-to-lymphocyte ratio predicted cognitive improvement in late-life depression treated with vortioxetine: Findings from an eight-week randomized controlled trial"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9922-5554","authenticated-orcid":false,"given":"Lingfeng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Bocharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.01.029_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.603979","article-title":"Vortioxetine prevents lipopolysaccharide-induced memory impairment without inhibiting the initial inflammatory cascade","volume":"11","author":"Alboni","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2025.01.029_b0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S1461145711001027","article-title":"A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder","volume":"15","author":"Alvarez","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.bbi.2025.01.029_b0025","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl] piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","article-title":"Depression and dementia: cause, consequence or coincidence?","volume":"79","author":"Bennett","year":"2014","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.bbi.2025.01.029_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-036859","article-title":"Neutrophil\u2013lymphocyte ratio across psychiatric diagnoses: a cross-sectional study using electronic health records","volume":"10","author":"Brinn","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbi.2025.01.029_b0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2011.07.239","article-title":"Treatment response and cognitive impairment in major depression: association with C-reactive protein","volume":"26","author":"Chang","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.01.029_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.psyneuen.2017.01.035","article-title":"HPA-axis and inflammatory reactivity to acute stress is related with basal HPA-axis activity","volume":"78","author":"Chen","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.01.029_b0055","article-title":"Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depression: an updated systematic review and meta-analysis","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Psych."},{"issue":"5","key":"10.1016\/j.bbi.2025.01.029_b0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/mp.2010.15","article-title":"Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors","volume":"16","author":"Conboy","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2025.01.029_b0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.bbi.2025.01.029_b0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/14740338.2022.2019705","article-title":"Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review","volume":"21","author":"De Diego-Adeli\u00f1o","year":"2022","journal-title":"Expert Opin. Drug Safety"},{"key":"10.1016\/j.bbi.2025.01.029_b0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2020.03.022","article-title":"Antidepressants of different classes cause distinct behavioral and brain pro-and anti-inflammatory changes in mice submitted to an inflammatory model of depression","volume":"268","author":"de Sousa","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2025.01.029_b0080","first-page":"2253","article-title":"Neutrophil\u2013lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy","author":"Demir","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2025.01.029_b0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.euroneuro.2023.02.006","article-title":"Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes","volume":"70","author":"Di Nicola","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.01.029_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11010058","article-title":"Neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio in bipolar disorder","volume":"11","author":"Fusar-Poli","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.bbi.2025.01.029_b0100","first-page":"199","article-title":"Guideline for good clinical practice","volume":"47","author":"G.C.P. Guideline","year":"2001","journal-title":"J. Postgrad. Med."},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/path.2104","article-title":"Immunosenescence of ageing","volume":"211","author":"Gruver","year":"2007","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.maturitas.2014.05.026","article-title":"Late-life depression in the primary care setting: challenges, collaborative care, and prevention","volume":"79","author":"Hall","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.bbi.2025.01.029_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","article-title":"Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder","volume":"95","author":"Haroon","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.bbi.2025.01.029_b0115","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.4088\/JCP.11m07470","article-title":"A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder","volume":"73","author":"Henigsberg","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2025.01.029_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2017.07.008","article-title":"Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats","author":"Hlavacova","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2025.01.029_b0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/JCP.0000000000000941","article-title":"Digit symbol substitution test: the case for sensitivity over specificity in neuropsychological testing","volume":"38","author":"Jaeger","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2025.01.029_b0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2025.01.029_b0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.psychres.2016.11.016","article-title":"Relationships of neutrophil\u2013lymphocyte and platelet\u2013lymphocyte ratios with the severity of major depression","volume":"247","author":"Kayhan","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2025.01.029_b0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.euroneuro.2021.09.006","article-title":"Depression and inflammation: correlation between changes in inflammatory markers with antidepressant response and long-term prognosis","volume":"54","author":"Kofod","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2025.01.029_b0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta\u2010analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.bbi.2025.01.029_b0150","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s12325-024-02826-9","article-title":"Assessing the effects of metabolic disruption, body mass index and inflammation on depressive symptoms in post-COVID-19 condition: a randomized controlled trial on vortioxetine","volume":"41","author":"Kwan","year":"2024","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2025.01.029_b0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","article-title":"Immune activation in brain aging and neurodegeneration: too much or too little?","volume":"64","author":"Lucin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2025.01.029_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.genhosppsych.2019.02.003","article-title":"Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders","volume":"58","author":"Mazza","year":"2019","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2025.01.029_b0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.bbi.2025.01.029_b0015","unstructured":"American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. Text revision."},{"key":"10.1016\/j.bbi.2025.01.029_b0180","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08923973.2024.2308268","article-title":"The effect of Vortioxetine on the NLRP3 pathway and microglial activity in the prefrontal cortex in an experimental model of depression","volume":"46","author":"Ozdamar Unal","year":"2024","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"4","key":"10.1016\/j.bbi.2025.01.029_b0190","first-page":"334","article-title":"Does late and early onset depression differ in terms of inflammation?","volume":"33","author":"Ozdin","year":"2020","journal-title":"Dusunen Adam."},{"key":"10.1016\/j.bbi.2025.01.029_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1039379","article-title":"Anti-inflammatory properties of commonly used psychiatric drugs","volume":"16","author":"Patel","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2025.01.029_b0200","article-title":"Investigation of peripheral inflammatory biomarkers in association with suicide risk in major depressive disorder","volume":"15","author":"Peth\u0151","year":"2024","journal-title":"Front. Psych."},{"issue":"10","key":"10.1016\/j.bbi.2025.01.029_b0205","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jagp.2017.03.016","article-title":"Longitudinal cognitive outcomes of clinical phenotypes of late-life depression","volume":"25","author":"Riddle","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"S1","key":"10.1016\/j.bbi.2025.01.029_b0210","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2021.269","article-title":"Effect of vortioxetine on proinflammatory cytokine levels in patients with heart failure and comorbid depression","volume":"64","author":"Sikora","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbi.2025.01.029_b0215","article-title":"A compendium of neuropsychological tests: administration, norms, and commentary","author":"Strauss","year":"2006","journal-title":"Am. Chem. Soc."},{"key":"10.1016\/j.bbi.2025.01.029_b0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jad.2022.04.038","article-title":"Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: a meta-analysis","volume":"308","author":"Su","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.bbi.2025.01.029_b0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bph.14074","article-title":"Vortioxetine exerts anti\u2010inflammatory and immunomodulatory effects on human monocytes\/macrophages","volume":"175","author":"Talmon","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2025.01.029_b0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/cells11030359","article-title":"Interconnections between inflammageing and immunosenescence during ageing","volume":"11","author":"Teissier","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0033291707001730","article-title":"Measuring depression: comparison and integration of three scales in the GENDEP study","volume":"38","author":"Uher","year":"2008","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.bbi.2025.01.029_b0240","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1017\/S0033291711001905","article-title":"Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms","volume":"42","author":"Uher","year":"2012","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0245","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/tp.2012.8","article-title":"Association of depressive disorders, depression characteristics and antidepressant medication with inflammation","volume":"2","author":"Vogelzangs","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2025.01.029_b0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.02.021","article-title":"Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis","volume":"79","author":"Wang","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2025.01.029_b0255","first-page":"47","article-title":"In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets","volume":"16","author":"Westrich","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.bbi.2025.01.029_b0175","series-title":"Mental health of older adults","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.bbi.2025.01.029_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2024.06.003","article-title":"Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: the role of age at first onset and change in depressive symptoms","author":"Xue","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.bbi.2025.01.029_b0265","doi-asserted-by":"crossref","first-page":"296","DOI":"10.9758\/cpn.2023.21.2.296","article-title":"Discrepancy between clinician-rated and self-reported depression severity is associated with adverse childhood experience, autistic-like traits, and coping styles in mood disorders","volume":"21","author":"Yamada","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.bbi.2025.01.029_b0020","unstructured":"World Medical Association (2008). Declaration of helsinki. Ethical Principles for Medical Research Involving Human Subjects 59th WMA General Assembly, Seoul."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:38:53Z","timestamp":1762313933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":53,"alternative-id":["S0889159125000406"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.01.029","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased neutrophil-to-lymphocyte ratio predicted cognitive improvement in late-life depression treated with vortioxetine: Findings from an eight-week randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}